Abstract
Background
Zhen-Wu-Bu-Qi Decoction (ZWBQD), a traditional Chinese medicine formula comprising Poria, Radix Paeoniae Alba, Rhizoma Atractylodis Macrocephalae, Rhizoma Zingiberis Recens, Radix Codonopsis and Rhizoma Coptidis, is used for treating ulcerative colitis (UC). In a previous study, we have reported ZWBQD mitigates the severity of dextran sulfate sodium (DSS)-induced colitis in mice.
Hypothesis
In this study, we aimed to understand the systemic actions and underlying mechanisms of ZWBQD on experimental colitis in mice.
Methods
We used multi-omics techniques and immunoblotting approach to study the pharmacological actions and mechanisms of ZWBQD in DSS-induced chronic colitic mice.
Results
We showed that ZWBQD exhibited potent anti-inflammatory properties and significantly protected DSS-induced colitic mice against colon injury by regulating the PI3K-AKT, MAPK signaling pathway and NF-κB signaling pathways. We also revealed that ZWBQD significantly ameliorated gut microbiota dysbiosis and abnormalities of tryptophan catabolites induced by DSS.
Conclusions
We demonstrated that the therapeutic effects of ZWBQD on experimental colitis are mediated by regulating multiple signaling pathways and modulation of gut microbiota. Our study employed an integrative strategy to elucidate novel mechanisms of ZWBQD, which provides new insights into the development of Chinese herbal medicine-based therapeutics for UC.
Original language | English |
---|---|
Article number | 154001 |
Journal | Phytomedicine |
Volume | 99 |
DOIs | |
Publication status | Published - May 2022 |
Scopus Subject Areas
- Drug Discovery
- Molecular Medicine
- Complementary and alternative medicine
- Pharmacology
- Pharmaceutical Science
User-Defined Keywords
- Chinese medicine
- Chronic colitis
- Metabolomics
- Metagenomics
- System pharmacology